Medication Automated Quotation System, or MEDAQ, Act of 2018
The source supplies the latest action, but no lifecycle stage.
Latest action (27 Jul 2018): Referred to the Subcommittee on Health.
What this bill does
H.R. 6593, the Medication Automated Quotation System (MEDAQ) Act of 2018, would direct the Government Accountability Office (GAO) to study the feasibility of creating an automated system to track prescription drug prices. This system, called MEDAQ, would be a searchable database that records the price paid per unit for prescription drugs by various purchasers.
The study would assess how to collect acquisition price data without revealing personally identifiable information, the costs of building and maintaining such a system, and whether new laws or regulations would be needed. It would also consider integrating existing systems like the FDA's NDC system and CMS's NADAC, and evaluate the potential for MEDAQ to lower drug prices by increasing competition and transparency.
This bill was introduced in the House of Representatives in July 2018 and was referred to the Committee on Energy and Commerce. As of now, its latest action is simply "Introduced." If enacted, the GAO would have 270 days after the bill becomes law to submit a report to Congress on the findings of the feasibility study.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Medication Automated Quotation System, or MEDAQ, Act of 2018
This bill requires the Government Accountability Office to study the feasibility of establishing a medication automated quotation system (i.e., an automated, searchable system that tracks the acquisition price per unit of prescription drugs and generates real-time reports).
Timeline
27 Jul 2018
Referred to the Subcommittee on Health.
Common questions
- What does H.R. 6593 do?
- H.R. 6593, the Medication Automated Quotation System (MEDAQ) Act of 2018, would direct the Government Accountability Office (GAO) to study the feasibility of creating an automated system to track prescription drug prices. This system, called MEDAQ, would be a searchable database that records the price paid per unit for prescription drugs by various purchasers. The study would assess how to collect acquisition price data without revealing personally identifiable information, the costs of building and maintaining such a system, and whether new laws or regulations would be needed. It would also consider integrating existing systems like the FDA's NDC system and CMS's NADAC, and evaluate the potential for MEDAQ to lower drug prices by increasing competition and transparency. This bill was introduced in the House of Representatives in July 2018 and was referred to the Committee on Energy and Commerce. As of now, its latest action is simply "Introduced." If enacted, the GAO would have 270 days after the bill becomes law to submit a report to Congress on the findings of the feasibility study.
- Has H.R. 6593 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 6593. Check the latest action and official source below.
- Who sponsored H.R. 6593?
- H.R. 6593 was sponsored by Rep. Duncan, John J., Jr. [R-TN-2] (R-TN), with 0 cosponsors.
- What's the latest action on H.R. 6593?
- Referred to the Subcommittee on Health. (27 Jul 2018).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.